E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/8/2012 in the Prospect News PIPE Daily.

Atossa Genetics prices $4 million initial public sale of common stock

Company sells 800,000 shares at $5.00 each via Dawson James Securities

By Devika Patel

Knoxville, Tenn., Nov. 8 - Atossa Genetics, Inc. said it priced a $4 million initial public offering of stock with a $600,000 greenshoe. The offering was announced Feb. 14, 2012.

The company will sell 800,000 common shares at $5.00 per share, which is identical to the Nov. 7 closing share price.

Dawson James Securities, Inc. is the bookrunner.

Atossa Genetics has produced a device that detects and tests for precursors to breast cancer. The company is based in Seattle.

Issuer:Atossa Genetics, Inc.
Issue:Common stock
Amount:$4 million
Greenshoe:$600,000
Shares:800,000
Price:$5.00
Warrants:No
Bookrunner:Dawson James Securities, Inc.
Announcement date:Feb. 14
Pricing date:Nov. 8
Stock symbol:Nasdaq: ATOS
Stock price:$5.00 at close Nov. 7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.